SOCRA Basic 2 — Questions and Answers
Question 1: What is the primary purpose of a clinical trial protocol?
- To provide a marketing plan for the drug
- To outline the objectives, design, methodology, and statistical considerations of a trial (Correct answer)
- To serve as a financial budget document
- To replace the investigator's brochure
Correct answer: To outline the objectives, design, methodology, and statistical considerations of a trial
A clinical trial protocol describes the objectives, design, methodology, statistical considerations, and organization of a clinical trial.
The clinical trial protocol is the cornerstone document of any clinical study. It provides detailed instructions on the study's objectives, design, methodology, statistical considerations, and organization. Regulatory agencies such as the FDA require that all clinical trials be conducted according to an approved protocol.
Question 2: Which phase of clinical trials is the first to involve human participants?
- Phase III
- Phase IV
- Phase I (Correct answer)
- Phase II
Correct answer: Phase I
Phase I is the first phase that involves human participants, typically testing safety, tolerability, and pharmacokinetics in a small group of healthy volunteers.
Phase I clinical trials are the first stage of testing a new drug in humans. They usually involve 20-100 healthy volunteers. The primary goals are to evaluate safety, determine safe dosage ranges, and identify side effects.
Question 3: What does GCP stand for in the context of clinical research?
- General Clinical Procedures
- Good Clinical Practice (Correct answer)
- Global Compliance Protocol
- Guided Clinical Pathways
Correct answer: Good Clinical Practice
GCP stands for Good Clinical Practice, an international ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials.
Good Clinical Practice (GCP) is an international ethical and scientific quality standard provided by ICH. ICH E6(R2) outlines GCP guidelines that ensure clinical trial data is credible and that participants' rights, safety, and well-being are protected.
Question 4: What is a placebo in clinical research?
- A higher dose of the investigational drug
- An inactive substance or treatment used as a comparator (Correct answer)
- A type of adverse event
- The standard of care treatment
Correct answer: An inactive substance or treatment used as a comparator
A placebo is an inactive substance designed to resemble the investigational product but contains no active therapeutic ingredients.
A placebo is an inactive substance designed to resemble the investigational product in appearance but contains no active therapeutic ingredients. Placebos are used to establish a baseline for comparison. The Declaration of Helsinki provides guidance on when placebo use is acceptable.
Question 5: Which document provides comprehensive information about the investigational product to the investigator?
- The case report form
- The informed consent form
- The investigator's brochure (Correct answer)
- The monitoring plan
Correct answer: The investigator's brochure
The Investigator's Brochure (IB) contains all relevant clinical and nonclinical data about the investigational product needed by investigators.
The Investigator's Brochure (IB) is a compilation of clinical and nonclinical data on the investigational product relevant to the study in human subjects. Per ICH E6, it should include physical, chemical, pharmaceutical, pharmacological, toxicological, pharmacokinetic, and clinical properties.
Question 6: What is the purpose of randomization in clinical trials?
- To ensure all participants receive the same treatment
- To reduce bias by randomly assigning participants to treatment groups (Correct answer)
- To select which sites will participate
- To determine the sample size
Correct answer: To reduce bias by randomly assigning participants to treatment groups
Randomization reduces selection bias and confounding by randomly assigning participants to different treatment groups, ensuring groups are comparable.
Randomization is a fundamental method that assigns participants to different treatment arms by chance rather than by choice. This helps ensure known and unknown confounding variables are evenly distributed, reducing selection bias and enabling valid statistical comparisons.
SOCRA Basic 2
What is the primary purpose of a clinical trial protocol?